BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound
First CDMO Project to Utilize In-house AI Tools for Discovery of Plant Cell Targets for the Botanical Synthesis ProcessRehovot, Israel--(Newsfile...
Day: May 21, 2025
Safe Supply Streaming Co. Ltd. Announces Addition of Donovan Bailey and Jerry Dias to Board of Directors
Toronto, Ontario--(Newsfile Corp. - May 21, 2025) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) ("Safe...
Red Light Holland’s FDA-Compliant, DEA-Registered Partner Irvine Labs Granted United States Controlled Substances Import Permit for the Company’s Raw Psilocybin Truffles
Red Light Holland is moving forward with the import of 3 kg (3000 grams) of raw psilocybin truffles from the...
Konica Minolta Healthcare to Launch Integrated Teleradiology Solution Powered by NewVue
Exa Platform Konica Minolta Healthcare's Exa® Platform facilitates the viewing of large medical image files across the enterprise. TAMPA, Fla....
Kaida BioPharma Announces New Partnership with Northway Biotech for the Manufacturing of KAD101
Represents significant milestone in the development of KAD101, a novel biologic prolactin receptor antagonist, being initially developed for the treatment...
Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study
Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery...
Galimedix Therapeutics publishes new data in peer-reviewed International Journal of Molecular Sciences demonstrating disease-modifying capability of GAL-201 in Alzheimer’s disease
Maintains Brain Connectivity: GAL-201 prevents amyloid-beta (Aβ)–induced synaptic damage by maintaining long-term potentiation, a correlate for learning and memory.Improves Memory...
The Beauty Health Company Announces Convertible Debt Refinancing
Refinancing extends maturity of existing debt and strengthens Company’s financial position to advance growth strategyLONG BEACH, Calif., May 21, 2025...
Soleno Therapeutics to Participate in Upcoming June Conferences
REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics...
Quipt Home Medical Confirms Receipt of Unsolicited Acquisition Proposal
CINCINNATI, May 21, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a...
All Three Leading Proxy Advisory Firms – ISS, Glass Lewis, and Egan-Jones – Recommend Zevra Stockholders Vote FOR the Company’s Director Nominees
ISS, Glass Lewis, and Egan-Jones Unanimously Conclude Mangless Has Not Made a Compelling Case for Change Board and Management Urge...
Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform
The Company demonstrated strong mucoadhesion and broad surface coverage in ex vivo nasal tissue models Raanana, Israel, May 21, 2025...
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
ALPHARETTA, Ga., May 21, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies...
Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences
MINNEAPOLIS, May 21, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies...
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary New recruit expands senior team...
Rapport Therapeutics to Host 2025 Investor and Analyst Day
BOSTON and SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company dedicated...
Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction
Investigator-initiated Phase 2 trial to evaluate TNX-102 SL’s potential to reduce severity of acute stress reaction (ASR) and frequency of...
Oruka Therapeutics to Present at the Jefferies Global Healthcare Conference
MENLO PARK, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company...
Tango Therapeutics Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas and Other Solid Tumors
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the...
Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
FRIENDSWOOD, Texas, May 21, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that...